In this episode of Cannabiz: The Business of Cannabis, the team explore the TGA’s potency audit, which found five out of 22 medical cannabis products tested failed to comply with required standards. The companies concerned have challenged the TGA’s findings. We ask editor-at-large Rhys Cohen: did the TGA jump the gun on potency tests?

Plus, journalist Rachel Williamson joins us to break down her special report, written exclusively for Cannabiz, which considers what Brexit means for Australian cannabis exporters. And finally, co-founders Martin Lane and Kim McKay discuss what they’ve learned in the last 11 weeks following the launch of Cannabiz.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Join or login
Elementum integer enim neque volutpat ac tincidunt vitae semper quis. Eu lobortis elementum nibh tellus molestie nunc. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Magnis dis parturient montes nascetur ridiculus. Dui id ornare arcu odio ut sem. Nisl nunc mi ipsum faucibus vitae.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Leave a comment